Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
about
Hematopoietic stem cell transplantation for people with ß-thalassaemia majorCustomizing the genome as therapy for the β-hemoglobinopathiesAlternative donor transplant of benign primary hematologic disordersThe potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challengesReduction of intramedullary apoptosis after stem cell transplantation in black african variant of pediatric sickle cell anemia.Transplantation tolerance: from theory to clinic.Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Hematopoietic stem cell transplantation for people with ß-thalassaemia major.Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease controlHigh-Resolution Analyses of Human Leukocyte Antigens Allele and Haplotype Frequencies Based on 169,995 Volunteers from the China Bone Marrow Donor Registry ProgramHaematopoietic stem cell transplantation in Nigerian sickle cell anaemia children patientsPlerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapyCorrection of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patientsGene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.Management of the thalassemiasSafe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation.Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia.Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell Disease.2017 Clinical trials update in new treatments of β-thalassemia.Emerging cellular and gene therapies for congenital anemias.Investigational drugs in phase I and phase II clinical trials for thalassemia.Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation.An LC-MS Assay with Isocratic Separation and On-line Solid Phase Extraction to Improve the Routine Therapeutic Drug Monitoring of Busulfan in Plasma.Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies.Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.Pathophysiology and treatment of patients with beta-thalassemia - an update.Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations
P2860
Q24193101-7FD813BC-370F-4771-BE5F-594E134F60DBQ26751061-40415EBF-D2A9-4845-B766-D59574B138C3Q26823398-EA557E9A-716E-496F-817D-6AB99AE7E78DQ28077484-761A37D6-DA8C-47D6-A502-8E9E966D8D9DQ33920142-6063589F-69F1-4F79-BD10-13A9979E6E65Q34082059-EF045202-3C8C-47CD-BC30-C5B0C90ECACAQ34343785-8F0433B4-9B14-4305-A13C-BB4120C0A6BBQ34546216-7FECF693-BBF7-4D54-8F7A-22FCA1E8AAF0Q35600557-B4CDAA2C-E5AE-4B80-A52C-D831CD5A7E90Q35793428-A7036C8D-AE77-4BF3-BEA8-090071E58BD5Q35898546-3D9D0A14-F7B3-460E-BBB8-090AF402E966Q35904935-6CC390FC-131F-4284-9E18-BA81BE1EA181Q36027459-9EC4DFE0-9470-4700-933A-8591FA1E18B1Q36650481-C95CCA76-712E-4BE1-B3CF-C25C67271BB6Q36654528-B2C9A710-7DA7-4EAC-B7CD-3D480AD7FF8BQ36870253-F36F99DE-D6EB-4ECE-AE01-2EB6E48D012AQ37623526-68E71065-F41F-415B-BB9F-A4D077FCA5B9Q37677242-ED5D80AC-D366-4934-A4EA-06A28A95E587Q38191280-F0666015-0862-4924-BF89-15BF24191922Q38387292-C9573254-16B8-428E-8A5D-36928035F503Q38514485-F2A44830-7CA5-41A3-84DA-FB6FB79EDFE0Q38685531-5A6FF3FE-DE71-4897-8F74-FE80AA4B7FB6Q38922283-1BF80793-5878-4FB0-BE2E-4676BC395035Q38993825-704E7CD0-2331-4AD5-8E6B-2583F45EFDC9Q39328286-2AEDF7F8-365F-497A-BE65-7069B1E380C1Q41453938-1FFC167D-DDC8-4D99-BB52-B4D042A7ED30Q42201727-C3E4D102-F5C8-4F9B-877D-33DC9AB4C804Q45872216-CEF1AF8A-0E50-4619-99D3-89159056108AQ47614537-361A7ECB-BB79-4D03-93E9-9E9F50E6EE0EQ48247015-EBCA6768-D5BC-47E9-B89E-781577A56B41Q50571229-C95764C8-6FAA-4903-8C9F-F781D1623652Q54585888-94DCE1C8-428C-474A-85DB-246B9ABC6A09
P2860
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@ast
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@en
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@nl
type
label
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@ast
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@en
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@nl
prefLabel
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@ast
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@en
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@nl
P2093
P2860
P1476
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia
@en
P2093
Guido Lucarelli
Javid Gaziev
Pietro Sodani
P2860
P304
P356
10.1101/CSHPERSPECT.A011825
P407
P50
P577
2012-05-01T00:00:00Z